Docetaxel Injection
Product Images NDC 23155-905

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 23155-905). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

160mg-8ml-carton.jpg (160mg 8ml Carton)

160mg-8ml-carton.jpg (160mg 8ml Carton)
This text provides information about Docetaxel Injection, a medication used for intravenous use to treat certain types of cancer. The text includes details on dosage, administration, composition, manufacturer details, and storage instructions. Docetaxel Injection is available in single-dose vials and should be discarded if unused. It contains docetaxel, anhydrous citric acid, polysorbate 80, and dehydrated alcohol. The text also includes warnings about handling the medication as it is a cytotoxic agent and should be kept out of reach of children. Storage instructions recommend keeping it between 2-25 °C and protected from light.*
FDA Label Image

160mg-8ml-vial.jpg (160mg 8ml Vial)

160mg-8ml-vial.jpg (160mg 8ml Vial)
This text contains information on a medication called Docetaxel, which is an injection solution with a concentration of 20 mg per milliliter. It is indicated for intravenous use only and is ready to be added to an infusion solution. The manufacturer is Avet Pharmaceuticals Inc., based in East Brunswick, NJ, with contact information provided. The medication is made in China. The text also advises to discard any unused portion and refers to the package insert for complete instructions. The revision date is 11/2024.*
FDA Label Image

20mg-ml-carton (20mg mL Carton)

20mg-ml-carton (20mg mL Carton)
The text is a pharmaceutical label for a product called "Docetaxel" from Sichuan Huiyu Pharmaceutical Co., Ltd. It contains information about the dosage, administration, and ingredients of the product. The label specifies that it is an injection solution for intravenous use only and gives instructions on how to prepare and administer the medication. The product is ready to add to an infusion solution. It also provides contact information for any queries or further instructions.*
FDA Label Image

20mg-ml-vial.jpg (20mg mL Vial)

20mg-ml-vial.jpg (20mg mL Vial)
FDA Label Image

80mg-4ml-carton.jpg (80mg 4ml Carton)

80mg-4ml-carton.jpg (80mg 4ml Carton)
This text is a detailed description of Docetaxel Injection, a medication used for intravenous use only. It contains 80 mg/4 mL and is ready to be added to an infusion solution. The manufacturer is Avet Pharma. The text also includes information about the composition of the solution and instructions for dosage and administration. The storage conditions and precautions are also mentioned.*
FDA Label Image

80mg-4ml-vial.jpg (80mg 4ml Vial)

80mg-4ml-vial.jpg (80mg 4ml Vial)
This text seems to be a label or package information for an injection manufactured by Avet Pharmaceuticals Inc. It contains details such as the address, phone number, dosage (20 mg/mL), expiration date (01/2024), and instructions for use. It is recommended to consult the package insert for complete instructions before using the medication.*
FDA Label Image
Avet Logo (Avet Logo)
FDA Label Image
Avet Logo (Avet Logo)
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
FDA Label Image

Figure 10 (Figure 10)

Figure 10 (Figure 10)
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
This is a graph showing survival probability (%) over different survival times (months). It provides insight into the likelihood of survival over specific time intervals.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
FDA Label Image

Figure 5 (Figure 5)

Figure 5 (Figure 5)
This is chart displaying survival time in months. The data points are given at intervals of 3, 6, 12, 18, 21, and 27 months.*
FDA Label Image

Figure 6 (Figure 6)

Figure 6 (Figure 6)
FDA Label Image

Figure 7 (Figure 7)

Figure 7 (Figure 7)
FDA Label Image

Figure 8 (Figure 8)

Figure 8 (Figure 8)
This text provides data on the Progression Free Survival (PFS) probability in percentage (%) at different time points (in months) – 12, 18, 24, 30. It shows a decreasing trend in PFS probability over time, with values ranging from 0% to 100%.*
FDA Label Image

Figure 9 (Figure 9)

Figure 9 (Figure 9)
This text provides survival probability percentages at different survival times in months. It shows the survival probability at time points such as 24, 30, 36, 42, 48, 54, and 60 months.*
FDA Label Image

Structural Formula (Structural Formula)

Structural Formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.